X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (131) 131
humans (109) 109
amyloidosis (80) 80
transthyretin (77) 77
wild-type transthyretin (73) 73
wild-type (64) 64
biochemistry & molecular biology (59) 59
male (45) 45
prealbumin - metabolism (45) 45
cardiac amyloidosis (43) 43
prealbumin - genetics (43) 43
female (42) 42
cardiac & cardiovascular systems (39) 39
cardiomyopathy (39) 39
middle aged (38) 38
aged (37) 37
liver-transplantation (37) 37
mutation (36) 36
senile systemic amyloidosis (34) 34
amyloid (32) 32
amyloid - metabolism (32) 32
medicine, general & internal (31) 31
heart-failure (30) 30
polyneuropathy (30) 30
prealbumin - chemistry (30) 30
diagnosis (29) 29
systemic amyloidosis (28) 28
amyloid neuropathies, familial - genetics (25) 25
medicine, research & experimental (24) 24
heart failure (23) 23
disease (22) 22
protein folding (22) 22
adult (21) 21
proteins (21) 21
aged, 80 and over (20) 20
amyloid - chemistry (20) 20
echocardiography (20) 20
liver transplantation (20) 20
amyloid neuropathies, familial - diagnosis (18) 18
amyloidosis - metabolism (17) 17
biophysics (17) 17
phenotype (17) 17
prognosis (17) 17
familial amyloidotic polyneuropathy (16) 16
medical and health sciences (16) 16
medicin och hälsovetenskap (16) 16
models, molecular (16) 16
analysis (15) 15
animals (15) 15
article (15) 15
fibril formation (15) 15
transplantation (15) 15
amyloid - genetics (14) 14
amyloid neuropathies, familial - pathology (14) 14
amyloid neuropathies, familial - therapy (14) 14
amyloidogenesis (14) 14
biopsy (14) 14
mass spectrometry (14) 14
prealbumin (14) 14
risk factors (14) 14
care and treatment (13) 13
heart (13) 13
light-chain amyloidosis (13) 13
research (13) 13
variant (13) 13
alzheimers-disease (12) 12
familial amyloid polyneuropathy (12) 12
progression (12) 12
amyloidosis - genetics (11) 11
cell biology (11) 11
heart diseases (11) 11
liver (11) 11
prevalence (11) 11
protein (11) 11
tafamidis (11) 11
transthyretin amyloidosis (11) 11
al amyloidosis (10) 10
amyloidosis - pathology (10) 10
clinical neurology (10) 10
deposition (10) 10
familial amyloidosis (10) 10
fibrils (10) 10
hereditary (10) 10
neuropathy (10) 10
preserved ejection fraction (10) 10
scintigraphy (10) 10
abridged index medicus (9) 9
amyloid fibril formation (9) 9
amyloid neuropathies, familial - complications (9) 9
cardiovascular magnetic-resonance (9) 9
denaturation (9) 9
genetic aspects (9) 9
hydrogen-ion concentration (9) 9
medical research (9) 9
mortality (9) 9
nutritional and metabolic diseases (9) 9
pathology (9) 9
protein binding (9) 9
protein conformation (9) 9
survival (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 9, pp. 819 - 829
Journal Article
Amyloid, ISSN 1350-6129, 6/2012, Volume 19, Issue S1, pp. 14 - 15
Current dogma for transthyretin (TTR) pathogenesis is that mutations in TTR alter its structure such that the tetramer becomes unstable and prone to release of... 
wild-type | Transthyretin | Wild-type | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | PREALBUMIN | Prealbumin - genetics | Amyloidosis - pathology | Prealbumin - metabolism | Amyloidosis - genetics | Humans | Protein Multimerization | Amyloidosis - metabolism | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, pp. e0173086 - e0173086
Aim: Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin... 
WILD-TYPE | BRAIN NATRIURETIC PEPTIDE | LIVER-TRANSPLANTATION | FIBRIL COMPOSITION | MYOCARDIAL-INFARCTION | HEREDITARY | MULTIDISCIPLINARY SCIENCES | DISEASE SEVERITY | CARDIOMYOPATHY | TROPONIN-T | SENILE SYSTEMIC AMYLOIDOSIS | Phenotype | Troponin T - blood | Amyloid Neuropathies, Familial - genetics | Humans | Genotype | Surveys and Questionnaires | Biomarkers - blood | Natriuretic Peptide, Brain - blood | Amyloid Neuropathies, Familial - physiopathology | Troponin I - blood | Amyloidosis | Research | Biological markers | Health aspects | Risk factors | Natriuretic peptides | Amyloidogenesis | Myocardial infarction | Brain | Senile | Heart attacks | Demography | Peptides | Syngeneic grafts | Cardiomyopathy | Laboratories | Liver | Transplantation | Ethics | Calcium-binding protein | Population | Bioindicators | Cardiology | Heart diseases | Genotypes | Public health | Age | Medical personnel | Brain natriuretic peptide | Review boards | Fibrils | Data processing | Breast cancer | Coronary artery disease | Mutants | Medical prognosis | Light chains | Data collection | Biomarkers | β-Amyloid | Skin | Ventricle | Mutation | Liver transplantation | Kidney transplantation | Cancer | Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 06/2017, Volume 38, Issue 24, pp. 1895 - 1904
Aims Wild-type transthyretin amyloidosis (ATTRwt) is mostly considered a disease predominantly of elderly male, characterized by concentric LV hypertrophy,... 
99mTc-DPD | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | Cardiac amyloidosis | Transthyretin | HEART-FAILURE | CARDIOMYOPATHY | GUIDELINES | Scintigraphy | EUROPEAN-SOCIETY | Wild-type
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 12/2015, Volume 9, pp. 6319 - 6325
Background: Causative treatment of patients with wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is lacking. Recent reports indicate the potential... 
Polyphenol | Cardiomyopathy | EGCG | Wild-type ATTR | SENILE CARDIAC AMYLOIDOSIS | CONTROLLED-TRIAL | DIAGNOSIS | POLYNEUROPATHY | CHEMISTRY, MEDICINAL | CARDIOVASCULAR MAGNETIC-RESONANCE | HEART-FAILURE | polyphenol | TAFAMIDIS | wild-type ATTR | PHARMACOLOGY & PHARMACY | cardiomyopathy | PROGRESSION | Amyloid - antagonists & inhibitors | Administration, Oral | Plant Extracts - pharmacology | Humans | Middle Aged | Hypertrophy, Left Ventricular - diagnosis | Catechin - administration & dosage | Male | Plant Extracts - isolation & purification | Plant Extracts - administration & dosage | Amyloid - metabolism | Aged, 80 and over | Amyloid Neuropathies, Familial - drug therapy | Catechin - isolation & purification | Catechin - therapeutic use | Aged | Catechin - analogs & derivatives | Hypertrophy, Left Ventricular - drug therapy | Catechin - pharmacology | Plant Extracts - therapeutic use | Tea - chemistry | Amyloid Neuropathies, Familial - diagnosis | Cohort Studies | Care and treatment | Usage | Amyloidosis | Heart diseases | Green tea | Health aspects | Materia medica, Vegetable | Plant extracts | Heart | Nuclear magnetic resonance--NMR | Males | Amyloid | Cardiology | Heart failure | Consumption | Catechin | Echocardiography | Transthyretin | Epigallocatechin-3-gallate | Wall thickness | Patients | Cholesterol | Laboratory tests | Studies | Tea | Magnetic resonance imaging | Morphology | Medical prognosis | Work stations | Ventricle | Ejection | Index Medicus
Journal Article
Amyloid, ISSN 1350-6129, 07/2015, Volume 22, Issue 3, pp. 175 - 180
Journal Article
Journal Article